Asthma mucus treatment study ends early with only 4 volunteers
NCT ID NCT03822637
First seen Mar 12, 2026 · Last updated May 09, 2026 · Updated 7 times
Summary
This study looked at whether a 20% N-acetylcysteine (NAC) solution could improve lung function and reduce mucus in people with moderate-to-severe asthma. Only 4 participants were enrolled before the study was terminated. Each person received both NAC and a placebo in two-week periods to compare effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF Airway Clinical Research Center
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.